Market Insights
Can the Magnificent Seven Keep Driving U.S. Markets?
Can the Magnificent Seven Still Power U.S.
ISIN:
XS2583354498
Buffettique Growth
Top Holdings:
Overview
What is the Buffettique Growth ETP?
The Buffettique Growth Strategy invests in ETPs, stocks and funds that relate to Warren Buffett’s investment career, going back to his early days’ focus on small caps to his present day’s investment in quality companies at fair prices. It invests 80% in a core portfolio of funds and the rest in a small portfolio of “Buffett-like” companies.
Multi-Factor and Multi-Theme
In a single trade, Buffettique Growth ETP delivers access to small caps, quality companies and disruptive macro-trends arising from technological advancements and consumer preferences.
Growth and Risk Management
Buffettique is designed to be a core building block for growth-oriented portfolios seeking less volatility exposure when markets are in “risk-off” mode.
Safety and Trust
1. Buffetique spans multiple segments and companies, including household names and newcomers, enjoying strong competitive advantages or geared to develop them and participate in future disruptions. 2.Trusted and experienced management team. 3. Offered in GBP, USD and EUR
NAV as of 22 Oct 2026
£15.04
52 WK: £11.21 – £15.17
1 Day NAV Change
-0.09 (-0.59%)
as of 22 Oct 2026
NAV Total Return
YTD: 4.70%
as of 22 Oct 2026
AUM
£3,101,847
as of 22 Oct 2026
Holdings
Full Holdings (.csv)Listings & Tickers
Key Facts
Investment Advisor
- Company Name
- Arcanum Asset Management Ltd
- Investor Relations
- Matt Rickard
- Compliance Contact
- Matt Rickard
- Company Website
- www.arcanum.co.uk/
- Contact
- www.arcanum.co.uk/contact
- Regulator
- FCA
Fees
- Annual Management Fee
- 1.00%
- Interest Paid On Cash Balances
- Performance Fee
- 10%
- Share Creation Fee
Tax & Legal
- ISA
- Eligible
- SIPP
- Eligible
- UK Fund Reporting Status
- Yes (effective 15/05/2023)
- US IRS Sec 871(m)
- Not applicable
- Today's Borrow Rate
Passported Countries:
United Kingdom
Italy
Germany
France
Spain
Netherlands
Ireland
Poland
Belgium
Sweden
Norway
Austria
* The information on this website regarding UK Fund Reporting Status is accurate as of the stated effective date (the "Effective Date"). Leverage Shares makes no representation or warranty that such information will remain accurate, complete or current thereafter, assumes no obligation to update it, and, to the fullest extent permitted by applicable law, accepts no responsibility or liability for any inaccuracies or omissions arising after the Effective Date.
Key Services Providers
- Issuer
- Leverage Shares plc
- Arranger
- Leverage Shares Management Company Limited
- Trustee
- Apex Corporate Trustees (UK) Limited
- Issuing and Paying Agent
- U.S. Bank Europe DAC
- Registrar
- U.S. Bank Europe DAC
- Portfolio Administrators
- Flexinvest Limited
- Stock Borrowing Provider and Custodian
- Interactive Brokers LLC, Morgan Stanley & Co. LLC and/or Pershing LLC
- Determination Agent
- Calculation Agent Services LLC
- Initial Authorised Participant
- BNP Paribas Arbitrage S.N.C.,Virtu Financial Ireland Limited, Flow Traders and others
- Sponsor
Fact Sheet
Reportable Income
UK Fund Reporting
EMT
Supplemental Trust Deeds
Supplement (CBI)
07 July 2026
Supplement (FCA)
07 July 2026
Prospectus (CBI)
11 June 2026
Prospectus (FCA)
09 June 2026
Prospectus (CBI)
13 March 2026
Prospectus (FCA)
13 March 2026
Prospectus (CBI)
23 June 2025
Prospectus (FCA)
23 June 2025
Prospectus (CBI)
17 July 2024
Prospectus (FCA)
17 July 2024
Prospectus (CBI)
15 March 2024
Prospectus (FCA)
15 March 2024
Prospectus (CBI)
18 October 2023
Prospectus (FCA)
18 October 2023
Prospectus (CBI)
04 May 2023
Prospectus (FCA)
04 May 2023
Supplement
01 June 2022
Prospectus
16 May 2022
Prospectus
07 December 2021
Supplement
08 October 2021
Supplement
17 September 2021
Supplement
06 May 2021
Supplement
04 March 2021
Prospectus
18 December 2020
Prospectus
06 November 2020
Prospectus
05 February 2020
Half Financial Year Ended
31.12.2025
Financial Year Ended
30.06.2025
Half Financial Year Ended
31.12.2024
Financial Year Ended
30.06.2024
Half Financial Year Ended
31.12.2023
Financial Year Ended
30.06.2023
Half Financial Year Ended
31.12.2022
Financial Year Ended
30.06.2022
Half Financial Year Ended
31.12.2021
Financial Year Ended
30.06.2021
Half financial year ended
31.12.2020
Financial Year Ended
30.06.2020
Half Financial Year Ended
31.12.2019
For the Year Ended
30.06.2019
From 01.07.18 to 31.12.18
31.12.2018
From 27.01.17 to 30.06.18
30.06.2018
Notices
Latest Notice
18.09.2026
Batch Notification
11.09.2026
Notice Appointment of Authorised Participants
26.08.2026
Notification of New Series
21.07.2026
Batch Notification
19.06.2026
Notice to ETP Securityholders
03.06.2026
Notices of Investment Strategy Modifications
21.05.2026
Batch Notification
30.04.2026
Notification of New Series
24.03.2026
Notification of New Series
23.03.2026
Batch Notification
11.03.2026
Notices of Investment Strategy Modifications
31.10.2025
Notice of Publication of Audited Financial Statements
06.08.2025
Updated to IB Margin Account Agreement
10.06.2025
Notice to ETP Securityholders
08.05.2025
Notice Appointment of Additional Authorised Participant
16.01.2025
Notice to ETP Securityholders
02.10.2024
Notice of Amended & Restated Margin Account Agreement
29.07.2024
Notice of Appointment of Pershing as Additional Margin Load Provider
17.07.2024
Notice of Deed of Amendment and Restatement
02.11.2023
Notice of Late Filing of Audited Financial Report
19.10.2023
Notice to ETP Securityholders
20.09.2023
Notice of Migration to IB LLC
04.05.2023
Notice of Amended and Restated Conditions
Related Articles
Market Insights
Market Insights
Best Performing AI ETFs in 2025
AI Frenzy Drives Record Flows into ETFs Artificial Intelligence (AI) is one of the defining megatrends of the 2020s, transforming industries and the global economy.
Market Insights
The Magnificent 7 Earnings Growth is Fading
Magnificent 7 year-over-year earnings growth has slowed for a fifth consecutive quarter Magnificent 7 stocks underperform the broader market YTD amid mixed earnings, tariffs uncertainty and concerns about rising company expenditures Nicknamed the Magnific
